Almirall, S.A. (FRA:E2Z)

Germany flag Germany · Delayed Price · Currency is EUR
10.52
-0.04 (-0.38%)
At close: Jul 4, 2025, 10:00 PM CET
11.91%
Market Cap 2.31B
Revenue (ttm) 1.03B
Net Income (ttm) 24.35M
Shares Out n/a
EPS (ttm) 0.11
PE Ratio 94.92
Forward PE 37.26
Dividend 0.15 (1.41%)
Ex-Dividend Date May 15, 2025
Volume 11
Average Volume 47
Open 10.52
Previous Close 10.56
Day's Range 10.52 - 10.52
52-Week Range 8.09 - 11.28
Beta n/a
RSI 43.72
Earnings Date Jul 25, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 2,026
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol E2Z
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.